MED PAPER (Morocco) Performance
| MED-PAPER | 20.10 0.40 1.95% |
The company secures a Beta (Market Risk) of 0.0128, which conveys not very significant fluctuations relative to the market. As returns on the market increase, MED PAPER's returns are expected to increase less than the market. However, during the bear market, the loss of holding MED PAPER is expected to be smaller as well. At this point, MED PAPER has a negative expected return of -0.2%. Please make sure to verify MED PAPER's standard deviation, maximum drawdown, kurtosis, as well as the relationship between the total risk alpha and potential upside , to decide if MED PAPER performance from the past will be repeated in the future.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days MED PAPER has generated negative risk-adjusted returns adding no value to investors with long positions. Even with latest weak performance, the Stock's basic indicators remain invariable and the latest agitation on Wall Street may also be a sign of long-running gains for the enterprise retail investors. ...more
MED |
MED PAPER Relative Risk vs. Return Landscape
If you would invest 2,296 in MED PAPER on September 2, 2024 and sell it today you would lose (286.00) from holding MED PAPER or give up 12.46% of portfolio value over 90 days. MED PAPER is generating negative expected returns and assumes 1.8114% volatility on return distribution over the 90 days horizon. Simply put, 16% of stocks are less volatile than MED, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
MED PAPER Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for MED PAPER's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as MED PAPER, and traders can use it to determine the average amount a MED PAPER's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.1094
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | MED-PAPER |
Estimated Market Risk
| 1.81 actual daily | 16 84% of assets are more volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.11 actual daily | 0 Most of other assets perform better |
Based on monthly moving average MED PAPER is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of MED PAPER by adding MED PAPER to a well-diversified portfolio.
Things to note about MED PAPER performance evaluation
Checking the ongoing alerts about MED PAPER for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for MED PAPER help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| MED PAPER generated a negative expected return over the last 90 days |
- Analyzing MED PAPER's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether MED PAPER's stock is overvalued or undervalued compared to its peers.
- Examining MED PAPER's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating MED PAPER's management team can have a significant impact on its success or failure. Reviewing the track record and experience of MED PAPER's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of MED PAPER's stock. These opinions can provide insight into MED PAPER's potential for growth and whether the stock is currently undervalued or overvalued.
Additional Tools for MED Stock Analysis
When running MED PAPER's price analysis, check to measure MED PAPER's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MED PAPER is operating at the current time. Most of MED PAPER's value examination focuses on studying past and present price action to predict the probability of MED PAPER's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MED PAPER's price. Additionally, you may evaluate how the addition of MED PAPER to your portfolios can decrease your overall portfolio volatility.